Terms: = Lung cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
496 results:
1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
2. Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce lung cancer Regrowth after Crizotinib Treatment.
Horvat NK; Chocarro S; Marques O; Bauer TA; Qiu R; Diaz-Jimenez A; Helm B; Chen Y; Sawall S; Sparla R; Su L; Klingmüller U; Barz M; Hentze MW; Sotillo R; Muckenthaler MU
ACS Nano; 2024 Apr; 18(17):11025-11041. PubMed ID: 38626916
[TBL] [Abstract] [Full Text] [Related]
3. Targeted therapeutic options in early and metastatic NSCLC-overview.
Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer.
Xu W; Liu X; Yan C; Abdurahmane G; Lazibiek J; Zhang Y; Cao M
Sci Rep; 2024 Mar; 14(1):7568. PubMed ID: 38555313
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Management of Patients with Non-Small Cell lung cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
[TBL] [Abstract] [Full Text] [Related]
6. Association between body fat decrease during the first year after diagnosis and the prognosis of idiopathic pulmonary fibrosis: CT-based body composition analysis.
Lee JY; Yoon SH; Goo JM; Park J; Lee JH
Respir Res; 2024 Feb; 25(1):103. PubMed ID: 38418966
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.
Zeng H; Zhang Y; Tan S; Huang Q; Pu X; Tian P; Li Y
BMC Pulm Med; 2024 Feb; 24(1):89. PubMed ID: 38365707
[TBL] [Abstract] [Full Text] [Related]
8. Longitudinal plasma proteomic profiling of EML4-alk positive lung cancer receiving alk-TKIs therapy.
Wang S; Hao X; Dai L; Lou N; Fan G; Gao R; Yang M; Xing P; Liu Y; Wang L; Zhang Z; Yao J; Tang L; Shi Y; Han X
Lung Cancer; 2024 Mar; 189():107503. PubMed ID: 38359741
[TBL] [Abstract] [Full Text] [Related]
9. 2021 WHO Classification of lung cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
10. Upfront Multiplex Gene Test Helps Prolong Survival in Advanced Non-small Cell lung cancer.
Kanasaki H; Ozawa Y; Nakamura N; Nagasaki K; Matsuyama W; Akahori D; Niwa M; Ogasawara T; Sato J
Anticancer Res; 2024 Feb; 44(2):723-730. PubMed ID: 38307579
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W
World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008
[TBL] [Abstract] [Full Text] [Related]
12. lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-alk and alk-EML4 in combined treatment of Alectinib and CyberKnife: A case report.
Li Y; Lu S; Yao P; Huang W; Huang Y; Zhou Y; Yuan Y; Cheng S; Wu F
Medicine (Baltimore); 2024 Jan; 103(3):e36992. PubMed ID: 38241569
[TBL] [Abstract] [Full Text] [Related]
13. Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (alk)-positive lung cancer and multiple brain metastases.
Murakami Y; Kawashima Y; Chiba S; Hara S; Yamazaki Y; Doman T; Saito S; Odaka T; Ogasawara T; Shimizu H; Sugisaka J; Aiba T; Toi Y; Yamanda S; Kimura Y; Sugawara S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1981. PubMed ID: 38212894
[TBL] [Abstract] [Full Text] [Related]
14. Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach.
Zhang X; Zhang G; Qiu X; Yin J; Tan W; Yin X; Yang H; Wang H; Zhang Y
Radiother Oncol; 2024 Feb; 191():110082. PubMed ID: 38195018
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological significances of cribriform pattern in lung adenocarcinoma.
Pyo JS; Lee BH; Min KW; Kim NY
Pathol Res Pract; 2024 Jan; 253():155035. PubMed ID: 38171080
[TBL] [Abstract] [Full Text] [Related]
16. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.
Wang L; Diao M; Zhang Z; Jiang M; Chen S; Zhao D; Liu Z; Zhou C
Lung Cancer; 2024 Jan; 187():107439. PubMed ID: 38113653
[TBL] [Abstract] [Full Text] [Related]
18. Effect of Tegafur-Uracil in Resected Stage IB lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.
Aoki M; Miyata R; Kamimura G; Harada Takeda A; Suetsugu T; Mizuno K; Ueda K
Ann Thorac Cardiovasc Surg; 2024 Jan; 30(1):. PubMed ID: 38105006
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical analysis of lung adenocarcinoma with epidermal growth factor receptor mutation transformed into sarcoma].
Zhu QQ; Du MZ; Wu WT; Guo LC; Huang JA; Shen D
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):24-30. PubMed ID: 38062690
[No Abstract] [Full Text] [Related]
20. Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell lung cancer: Results From the CANOPY-1 Trial.
Tan DSW; Felip E; de Castro G; Solomon BJ; Greystoke A; Cho BC; Cobo M; Kim TM; Ganguly S; Carcereny E; Paz-Ares L; Bennouna J; Garassino MC; Schenker M; Kim SW; Brase JC; Bury-Maynard D; Passos VQ; Deudon S; Dharan B; Song Y; Caparica R; Johnson BE
J Clin Oncol; 2024 Jan; 42(2):192-204. PubMed ID: 38039427
[TBL] [Abstract] [Full Text] [Related]
[Next]
